Immediate Impact
2 standout
Citing Papers
Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Works of Naren Basu being referenced
Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis
2015
Contralateral Risk-Reducing Mastectomy: Review of Risk Factors and Risk-Reducing Strategies
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Naren Basu | 42 | 34 | 7 | 31 | 10 | 94 | |
| Sampara Vasishta | 16 | 20 | 5 | 18 | 14 | 172 | |
| M Lenhard | 25 | 23 | 6 | 12 | 15 | 100 | |
| Paul S. Lavik | 37 | 28 | 8 | 15 | 168 | ||
| Anne‐May Österholm | 28 | 49 | 19 | 32 | 11 | 175 | |
| Muneyasu Takeda | 51 | 7 | 6 | 7 | 12 | 176 | |
| Irene Hadjidemetriou | 50 | 26 | 2 | 33 | 9 | 174 | |
| Bernhard Volz | 13 | 37 | 9 | 9 | 10 | 100 | |
| Yves–Jean Bignon | 32 | 43 | 20 | 42 | 9 | 166 | |
| Gerard Moskowitz | 59 | 9 | 5 | 30 | 10 | 127 | |
| Giovanna Traficante | 30 | 11 | 20 | 43 | 10 | 101 |
All Works
Loading papers...